Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Liabilities from Discontinued Operations (2010 - 2023)

Revvity's (RVTY) quarterly Liabilities from Discontinued Operations came in at $272.9 million in Q1 2023, up 32.72% on a YoY basis from $205.6 million in Q1 2022, and up 16.22% quarter-over-quarter from $234.8 million in Q4 2022.

Analysis

Revvity (RVTY) Liabilities from Discontinued Operations (2010 - 2023) Analysis & Trends

Revvity (RVTY) has reported Liabilities from Discontinued Operations for 14 consecutive years, with $272.9 million the latest figure, recorded in Q1 2023.

  • For the quarter ending Q1 2023, Liabilities from Discontinued Operations rose 32.72% year-over-year to $272.9 million; the trailing twelve-month figure through Jan 2023 stood at $272.9 million (up 32.72% YoY), and the FY2023 full-year result was $272.9 million, up 32.72% from the prior year.
  • Liabilities from Discontinued Operations advanced to $272.9 million in Q1 2023 per RVTY's latest filing, from $234.8 million in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at $272.9 million in Q1 2023 and bottomed at $2.1 million in Q3 2020.
  • Historically, Liabilities from Discontinued Operations has averaged $66.4 million across 5 years, with a median of $2.1 million in 2019.
  • The sharpest annual moves came in 2019 and 2022: Liabilities from Discontinued Operations slipped 2.45% in 2019, then surged 9361.3% in 2022.
  • Over 5 years, Liabilities from Discontinued Operations stood at $2.1 million in 2019, then dropped by 0.71% to $2.1 million in 2020, then rose by 3.62% to $2.2 million in 2021, then soared by 10704.79% to $234.8 million in 2022, then grew by 16.22% to $272.9 million in 2023.
  • According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered $272.9 million, $234.8 million, and $205.6 million for Q1 2023, Q4 2022, and Q1 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jan 1, 2023 272.87 Mn
Oct 2, 2022 234.79 Mn
Jan 2, 2022 205.59 Mn
Jan 3, 2021 2.17 Mn
Oct 4, 2020 2.10 Mn
Jul 5, 2020 2.10 Mn
Apr 5, 2020 2.11 Mn
Dec 29, 2019 2.11 Mn
Sep 29, 2019 2.11 Mn
Jun 30, 2019 2.13 Mn
Mar 31, 2019 2.13 Mn
Dec 30, 2018 2.17 Mn
Sep 30, 2018 2.17 Mn
Jul 1, 2018 2.17 Mn
Apr 1, 2018 2.15 Mn
Dec 31, 2017 2.10 Mn
Oct 1, 2017 2.15 Mn
Jul 2, 2017 6.37 Mn
Apr 2, 2017 46.22 Mn
Jan 1, 2017 41.93 Mn